{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:19:03Z","timestamp":1791231543623,"version":"4.1.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020469","name":"Universidad Cient\u00edfica del Sur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020469","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.heliyon.2024.e37224","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T14:42:01Z","timestamp":1725028921000},"page":"e37224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Is primary breast melanoma a true pathological entity? The argument against it"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6987-5030","authenticated-orcid":false,"given":"Alexis R.","family":"Narvaez-Rojas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0390-2048","authenticated-orcid":false,"given":"Samantha","family":"Linhares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaina","family":"Sedighim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4359-5556","authenticated-orcid":false,"given":"Kyle Daniel","family":"Klingbeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6410-2300","authenticated-orcid":false,"given":"Clara","family":"Milikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Elgart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Jaimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Feun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Lutzky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"De la Cruz Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Avisar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mecker G.","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.heliyon.2024.e37224_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37224_bib2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/cancers3010126","article-title":"Decoding melanoma metastasis","volume":"3","author":"Damsky","year":"2010","journal-title":"Cancers"},{"key":"10.1016\/j.heliyon.2024.e37224_bib4","article-title":"Metastatic melanoma \u2013 a review of current and future treatment options","volume":"95","author":"Maverakis","year":"2014","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.heliyon.2024.e37224_bib5","series-title":"StatPearls [Internet]","article-title":"Malignant melanoma","author":"Heistein","year":"2024"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37224_bib6","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/tbj.12661","article-title":"Primary noncutaneous malignant melanoma of the breast","volume":"22","author":"Rassouli","year":"2016","journal-title":"Breast J."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37224_bib7","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jaad.2019.04.034","article-title":"Anatomic location of primary melanoma: survival differences and sun exposure","volume":"81","author":"Howard","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37224_bib8","first-page":"39","article-title":"Primary malignant melanoma of the breast","volume":"2","author":"Bernardo","year":"1980","journal-title":"Acta medica portuguesa"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37224_bib9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/jso.2930480208","article-title":"Metastases to the breast: differential diagnosis from primary breast carcinoma","volume":"48","author":"Vergier","year":"1991","journal-title":"J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37224_bib10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/(SICI)1097-0142(19980625)84:3<160::AID-CNCR7>3.0.CO;2-S","article-title":"Malignant melanoma metastatic to the breast: a report of seven cases diagnosed by fine-needle aspiration cytology","volume":"84","author":"Cangiarella","year":"1998","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37224_bib11","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/(SICI)1097-0339(200004)22:4<246::AID-DC10>3.0.CO;2-Q","article-title":"A case of amelanotic spindle-cell melanoma presenting as metastases to breast and axillary lymph node: diagnosis by FNA cytology","volume":"22","author":"Kobayashi","year":"2000","journal-title":"Diagn. Cytopathol."},{"key":"10.1016\/j.heliyon.2024.e37224_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4048\/jkbcs.2003.6.1.35","article-title":"A case of malignant melanoma presenting as a breast mass","volume":"6","author":"Kim","year":"2003","journal-title":"Journal of Korean Breast Cancer Society"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37224_bib13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1159\/000326390","article-title":"Spindle cell malignant melanoma metastatic to the breast from a pigmented lesion on the back. A case report","volume":"48","author":"Mayayo Artal","year":"2004","journal-title":"Acta Cytol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37224_bib14","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1365-2133.2005.06574.x","article-title":"Management of melanoma metastasis to the breast: case series and review of the literature","volume":"152","author":"Loffeld","year":"2005","journal-title":"Br. J. Dermatol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37224_bib15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/jso.20592","article-title":"Metastatic melanoma in the breast: a report of 27 cases","volume":"94","author":"Ravdel","year":"2006","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.heliyon.2024.e37224_bib16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1477-7819-5-74","article-title":"Metastatic disease to the breast: the Washington University experience","volume":"5","author":"Vaughan","year":"2007","journal-title":"World J. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37224_bib17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/CMR.0b013e328317f04b","article-title":"Unusual presentation of metastatic amelanotic melanoma of unknown primary origin as a solitary breast lump","volume":"18","author":"Roy","year":"2008","journal-title":"Melanoma Res."},{"key":"10.1016\/j.heliyon.2024.e37224_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.07.2008.0433","article-title":"In-transit metastasis of the breast region from malignant melanoma of the trunk","volume":"2009","author":"Uludag","year":"2009","journal-title":"BMJ Case Rep."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37224_bib19","first-page":"149","article-title":"Breast metastasis from a melanoma","volume":"12","author":"Al Samaraee","year":"2012","journal-title":"Ochsner J."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37224_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5858\/arpa.2011-0552-OA","article-title":"Metastatic melanoma presenting as an isolated breast tumor: a study of 20 cases with emphasis on several primary mimickers","volume":"137","author":"Bacchi","year":"2013","journal-title":"Archives of pathology & laboratory medicine"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37224_bib21","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s12282-010-0231-8","article-title":"Primary amelanotic melanoma of the breast: combating a rare cancer","volume":"21","author":"Biswas","year":"2014","journal-title":"Breast cancer (Tokyo, Japan)"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37224_bib22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3892\/ol.2014.2120","article-title":"Primary malignant melanoma of the breast: a case report and review of the literature","volume":"8","author":"He","year":"2014","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37224_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijscr.2013.10.014","article-title":"Metastatic breast disease from cutaneous malignant melanoma","volume":"5","author":"Moschetta","year":"2014","journal-title":"International journal of surgery case reports"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37224_bib24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4103\/0377-4929.134720","article-title":"Malignant melanoma of breast: a unique case with diagnostic dilemmas","volume":"57","author":"Vasudevan","year":"2014","journal-title":"Indian J. Pathol. Microbiol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37224_bib25","article-title":"Malignant melanoma of male breast with nodal metastasis, Medical Journal of Dr","volume":"7","author":"Srikanth","year":"2014","journal-title":"D.Y. Patil University"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37224_bib26","first-page":"1709","article-title":"Primary malignant melanoma of the breast: case report and review of the literature","volume":"35","author":"Drueppel","year":"2015","journal-title":"Anticancer research"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37224_bib27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s13256-016-1117-y","article-title":"Intramammary metastatic melanoma of unknown primary origin in a 58-year old patient: a case report","volume":"10","author":"El-Tani","year":"2016","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.heliyon.2024.e37224_bib28","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.2147\/OTT.S107271","article-title":"Anorectal melanoma metastatic to the breast: a case report and review of the literature","volume":"9","author":"Feng","year":"2016","journal-title":"OncoTargets Ther."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e37224_bib29","first-page":"Ed08","article-title":"Amelanotic signet ring cell melanoma presenting as breast lump- A diagnostic conundrum","volume":"11","author":"Sathiah","year":"2017","journal-title":"J. Clin. Diagn. Res. : J. Clin. Diagn. Res."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37224_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4132\/jptm.2018.10.18","article-title":"Primary malignant melanoma of the breast: a report of two cases","volume":"53","author":"Koh","year":"2019","journal-title":"Journal of pathology and translational medicine"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37224_bib31","first-page":"354","article-title":"Metastatic malignant melanoma of the breast: report of a case and review of the literature","volume":"64","author":"Mastoraki","year":"2022"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e37224_bib32","article-title":"Primary melanoma of the breast parenchyma: an oncoplastic approach","volume":"8","author":"Snashall","year":"2020","journal-title":"Plastic and reconstructive surgery. Global open"},{"key":"10.1016\/j.heliyon.2024.e37224_bib33","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.921360","article-title":"Diagnostic delays in metastatic amelanotic melanoma presenting as breast pain","volume":"21","author":"Do","year":"2020","journal-title":"The American journal of case reports"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e37224_bib34","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.radcr.2020.08.009","article-title":"Metastatic melanoma presenting as a breast mass - role of radiologist as a clinician","volume":"15","author":"Sharma","year":"2020","journal-title":"Radiology case reports"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37224_bib35","article-title":"Metastatic malignant melanoma with occult primary presenting as breast mass: a case report and literature review","volume":"13","author":"Harsten","year":"2021","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37224_bib42","first-page":"710","article-title":"TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative","volume":"34","author":"Ai","year":"2021","journal-title":"breast cancer"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37224_bib60","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/1097-0339(200007)23:1<46::AID-DC11>3.0.CO;2-F","article-title":"Fine-needle aspiration of a metaplastic breast carcinoma with extensive melanocytic differentiation: a case report","volume":"23","author":"Yen","year":"2000","journal-title":"Diagn. Cytopathol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37224_bib36","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/jjco\/hyi068","article-title":"Different manifestations of malignant melanoma in the breast: a report of 12 cases and a review of the literature","volume":"35","author":"Kurul","year":"2005","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37224_bib37","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/cncr.20866","article-title":"Incidence of noncutaneous melanomas in the U.S","volume":"103","author":"McLaughlin","year":"2005","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37224_bib38","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1365-2559.1998.00312.x","article-title":"Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants","volume":"32","author":"Blessing","year":"1998","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37224_bib39","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1600-0560.2007.00891.x","article-title":"Immunohistochemical characteristics of melanoma","volume":"35","author":"Ohsie","year":"2008","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.heliyon.2024.e37224_bib40","unstructured":"INVALID CITATION !!!)."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e37224_bib41","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0046-8177(87)80382-9","article-title":"S-100 protein positivity in breast carcinomas: a potential pitfall in diagnostic immunohistochemistry","volume":"18","author":"Dwarakanath","year":"1987","journal-title":"Hum. Pathol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37224_bib43","doi-asserted-by":"crossref","first-page":"475","DOI":"10.59249\/WPKX7733","article-title":"Melanoma in the breast: a diagnostic challenge","volume":"96","author":"John","year":"2023","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.heliyon.2024.e37224_bib44","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.humpath.2016.05.021","article-title":"SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma\/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma","volume":"56","author":"Hsieh","year":"2016","journal-title":"Hum. Pathol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37224_bib45","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/10668969231177702","article-title":"Pigmented epidermotropic breast carcinoma: a diagnostic pitfall mimicking melanoma A case report and literature review","volume":"32","author":"Rolim","year":"2024","journal-title":"Int. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37224_bib46","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jso.21453","article-title":"Characteristics of metastasis in the breast from extramammary malignancies","volume":"101","author":"Lee","year":"2010","journal-title":"J. Surg. Oncol."},{"issue":"5\u20136","key":"10.1016\/j.heliyon.2024.e37224_bib47","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.canep.2009.04.001","article-title":"Melanoma metastasis to the breast: a diagnostic pitfall","volume":"32","author":"Bahat","year":"2009","journal-title":"Cancer Detect. Prev."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37224_bib48","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/(SICI)1096-9098(199911)72:3<175::AID-JSO11>3.0.CO;2-D","article-title":"Bilateral breast masses as initial presentation of widely metastatic melanoma","volume":"72","author":"Majeski","year":"1999","journal-title":"J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37224_bib49","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/CMR.0b013e328334c39a","article-title":"Primary malignant melanoma at unusual sites: an institutional experience with review of literature","volume":"20","author":"Das","year":"2010","journal-title":"Melanoma Res."},{"key":"10.1016\/j.heliyon.2024.e37224_bib50","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ctrv.2018.08.011","article-title":"Multidisciplinary treatment strategies in high-risk resectable melanoma: role of adjuvant and neoadjuvant therapy","volume":"70","author":"McKean","year":"2018","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.heliyon.2024.e37224_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1340408","article-title":"Multidisciplinary approach and treatment of acral and mucosal melanoma","volume":"14","author":"Fortuna","year":"2024","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37224_bib52","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0002-9610(59)90440-4","article-title":"Malignant melanoma of the breast","volume":"97","author":"Stephenson","year":"1959","journal-title":"Am. J. Surg."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37224_bib53","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/dvdy.24226","article-title":"Tumors of the neural crest: common themes in development and cancer","volume":"244","author":"Maguire","year":"2015","journal-title":"Dev. Dynam. : an official publication of the American Association of Anatomists"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e37224_bib54","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1440-1827.2009.02426.x","article-title":"Metaplastic breast carcinoma with melanocytic differentiation","volume":"59","author":"Bendic","year":"2009","journal-title":"Pathol. Int."},{"issue":"26","key":"10.1016\/j.heliyon.2024.e37224_bib55","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37224_bib56","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.surg.2005.10.016","article-title":"Breast cancer metastatic to renal cell carcinoma","volume":"139","author":"M\u00f6ller","year":"2006","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37224_bib57","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3348\/kjr.2014.15.1.20","article-title":"Breast metastases from extramammary malignancies: typical and atypical ultrasound features","volume":"15","author":"Mun","year":"2014","journal-title":"Korean J. Radiol."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e37224_bib58","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.gyobfe.2013.09.013","article-title":"[Mammary metastasis of extramammary cancers: current knowledge and diagnostic difficulties]","volume":"41","author":"Koch","year":"2013","journal-title":"Gynecol. Obstet. Fertil."},{"key":"10.1016\/j.heliyon.2024.e37224_bib59","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/1757-1626-1-212","article-title":"Primary cutaneous melanoma of the breast: a case report","volume":"1","author":"Alzaraa","year":"2008","journal-title":"Cases journal"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37224_bib61","first-page":"442","article-title":"Melanoma from unknown primary site and amelanotic melanoma","volume":"9","author":"Giuliano","year":"1982","journal-title":"Semin. Oncol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37224_bib62","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/00000478-198702000-00008","article-title":"Malignant melanoma primary in lymph node. The case of the missing link","volume":"11","author":"Shenoy","year":"1987","journal-title":"Am. J. Surg. Pathol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37224_bib63","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0033-1343989","article-title":"Development of the human breast","volume":"27","author":"Javed","year":"2013","journal-title":"Semin. Plast. Surg."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37224_bib64","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.breast.2004.02.006","article-title":"Breast metastases from cutaneous malignant melanoma","volume":"13","author":"Bassi","year":"2004","journal-title":"Breast"},{"issue":"19","key":"10.1016\/j.heliyon.2024.e37224_bib65","article-title":"The breast tumor microenvironment: a key player in metastatic spread","volume":"13","author":"Terceiro","year":"2021"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37224_bib66","doi-asserted-by":"crossref","first-page":"712","DOI":"10.21614\/chirurgia.113.5.712","article-title":"Breast metastasis as a presentation of malignant melanoma","volume":"113","author":"Asaad","year":"2018","journal-title":"Chirurgia"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37224_bib67","first-page":"141","article-title":"Surgical considerations and systemic therapy of melanoma","volume":"100","author":"Gamboa","year":"2020","journal-title":"Surg. Clin."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37224_bib68","first-page":"335","article-title":"Managing metastatic melanoma in 2022: a clinical review","volume":"18","author":"Switzer","year":"2022"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37224_bib69","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/bjd.13675","article-title":"No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report","volume":"172","author":"Sladden","year":"2015","journal-title":"Br. J. Dermatol."},{"issue":"25","key":"10.1016\/j.heliyon.2024.e37224_bib70","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"J. Clin. Oncol. : official journal of the American Society of Clinical Oncology"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e37224_bib71","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.1999.17.9.2745","article-title":"Phase III multicenter randomized trial of the dartmouth regimen versus dacarbazine in patients with metastatic melanoma","volume":"17","author":"Chapman","year":"1999","journal-title":"J. Clin. Oncol."},{"issue":"34","key":"10.1016\/j.heliyon.2024.e37224_bib72","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1200\/JCO.2007.12.0253","article-title":"Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta-analysis of 18 trials involving 2,621 patients","volume":"25","author":"Ives","year":"2007","journal-title":"J. Clin. Oncol. : official journal of the American Society of Clinical Oncology"},{"issue":"16","key":"10.1016\/j.heliyon.2024.e37224_bib73","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","article-title":"Five-year survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"381","author":"Larkin","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e37224_bib74","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S1470-2045(19)30388-2","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study","volume":"20","author":"Robert","year":"2019","journal-title":"Lancet Oncol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e37224_bib75","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"15_suppl","key":"10.1016\/j.heliyon.2024.e37224_bib76","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.15_suppl.9531","article-title":"The anti\u2013PD-1 antibody spartalizumab (S) in combination with dabrafenib (D) and trametinib (T) in previously untreated patients (pts) with advanced BRAF V600\u2013mutant melanoma: updated efficacy and safety from parts 1 and 2 of COMBI-i","volume":"37","author":"Long","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"19","key":"10.1016\/j.heliyon.2024.e37224_bib77","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa1708539","article-title":"Adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanoma","volume":"377","author":"Long","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37224_bib78","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jamaoncol.2018.4514","article-title":"Survival outcomes in patients with previously untreated BRAF wild-type advanced melanoma treated with nivolumab therapy: three-year follow-up of a randomized phase 3 trial","volume":"5","author":"Ascierto","year":"2019","journal-title":"JAMA Oncol."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e37224_bib79","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1659096","article-title":"Beneficial modulation of the tumor microenvironment and generation of anti-tumor responses by TLR9 agonist lefitolimod alone and in combination with checkpoint inhibitors","volume":"8","author":"Kapp","year":"2019","journal-title":"OncoImmunology"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37224_bib80","first-page":"24","article-title":"Relatlimab and nivolumab versus nivolumab in untreated advanced melanoma","volume":"386","author":"Tawbi","year":"2022"},{"key":"10.1016\/j.heliyon.2024.e37224_bib81","article-title":"The prognostic significance of VISTA and CD33-positive myeloid cells in cutaneous melanoma and their relationship with PD-1 expression","volume":"10","author":"Choi","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37224_bib82","article-title":"Tim-3 finds its place in the cancer immunotherapy landscape","volume":"8","author":"Acharya","year":"2020"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37224_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9010223","article-title":"Anti-PD-1 and novel combinations in the treatment of melanoma-an update","volume":"9","author":"Gellrich","year":"2020","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37224_bib84","first-page":"4734","article-title":"Viral vector-mediated reprogramming of the fibroblastic tumor stroma sustains curative melanoma treatment","volume":"12","author":"Ring","year":"2021"},{"key":"10.1016\/j.heliyon.2024.e37224_bib85","doi-asserted-by":"crossref","DOI":"10.1038\/s41416-022-01942-z","article-title":"Clinical and genomic correlates of imatinib response in melanomas with KIT alterations","volume":"127","author":"Jung","year":"2022","journal-title":"British journal of cancer"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37224_bib86","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s13555-021-00525-9","article-title":"Looking into a better future: novel therapies for metastatic melanoma","volume":"11","author":"Villani","year":"2021","journal-title":"Dermatology and therapy"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e37224_bib87","first-page":"651","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37224_bib88","first-page":"54","article-title":"Human epidermal growth factor receptor 3 serves as a novel therapeutic target for acral melanoma","volume":"9","author":"Tanaka","year":"2023"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e37224_bib89","first-page":"2212","article-title":"A phase 1\/2 trial of an immune-modulatory vaccine against Ido\/PD-L1 in combination with nivolumab in metastatic melanoma","volume":"27","author":"Kjeldsen","year":"2021"},{"key":"10.1016\/j.heliyon.2024.e37224_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104163","article-title":"Gut microbiome in modulating immune checkpoint inhibitors","volume":"82","author":"Li","year":"2022","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37224_bib91","first-page":"1536","article-title":"Epigenetic modulation reveals differentiation state specificity of oncogene addiction","volume":"12","author":"Khaliq","year":"2021"},{"key":"10.1016\/j.heliyon.2024.e37224_bib92","unstructured":"National Cancer Institute. Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients with Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial. NCI-Supported Clinical Trials. Available in: https:\/\/www.cancer.gov\/research\/participate\/clinical-trials-search\/v?id=NCI-2020-04463&r=1."},{"key":"10.1016\/j.heliyon.2024.e37224_bib93","unstructured":"National Cancer Institute. An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942). NCI-Supported Clinical Trials. Available in: https:\/\/www.cancer.gov\/research\/participate\/clinical-trials-search\/v?id=NCI-2019-04957&r=1."},{"key":"10.1016\/j.heliyon.2024.e37224_bib94","unstructured":"National Cancer Institute. A Study of Adjuvant Pembrolizumab\/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010\/KEYVIBE-010). NCI-Supported Clinical Trials. Available in: https:\/\/www.cancer.gov\/research\/participate\/clinical-trials-search\/v?id=NCI-2023-02088&r=1."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024132550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024132550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:39:25Z","timestamp":1790714365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024132550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":93,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2405844024132550"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37224","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is primary breast melanoma a true pathological entity? The argument against it","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37224","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e37224"}}